INNOVIVE PHARMACEUTICALS, INC.

NEW YORK, NY How do I update this listing?

Create Email Alert

Innovive Pharmaceuticals is based out of New York. Innovive Pharmaceuticals, Inc., a development stage biopharmaceutical company, develops compounds for the treatment of cancer. Its products include INNO-406, a Phase I clinical trial product that inhibits the Bcr-Abl and the Lyn tyrosine kinases activation; tamibarotene, a synthetic retinoid for the treatment of acute promyelocytic leukemia; INNO-206, a prodrug for doxorubicin that is used for the treatment of various cancers, including breast cancer, lung cancer, sarcomas, and lymphomas; and INNO-305, a WT1 peptide immunotherapeutic for the treatment of solid tumors and leukemias, including acute myelogenous leukemia.Whalewisdom has at least 22 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

innovive pharmaceuticals, inc.
555 MADISON AVENUE, 25TH FLOOR
NEW YORK NY    10022

Business Phone: 212-716-1810
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments